Funds · CLYM

Who owns CLYM?

Institutional ownership of Climb Bio Inc. from Form 13F, Q2 2026

109 institutional managers reported holding Climb Bio Inc. (CLYM) in Form 13F filings for Q2 2026, with 56,329,704 shares worth $734M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 24,040,535 shares (+74.5%). 52 opened new positions and 22 sold out.

Funds holding
109
Value held
$734M
New / sold out
52 / 22
Net shares, same filers
+74.5%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of CLYM

FundValueShare of 13F holdingsSharesMove
Ra Capital Management, L.p.$147M20.1%11,300,939Unchanged
FMR LLC$88.5M12.1%6,790,364Added
UBS Group AG$44.4M6.0%3,404,866Added
Braidwell LP$36.5M5.0%2,797,375Added
Adage Capital Partners GP, L.l.c.$32.7M4.4%2,506,000New
BlackRock, Inc.$30.7M4.2%2,354,872Added
Price T Rowe Associates Inc$27.7M3.8%2,127,281Added
Cormorant Asset Management, LP$27.5M3.7%2,106,000New
Frontier Capital Management Co LLC$25.3M3.4%1,939,019New
Vanguard Capital Management LLC$22.2M3.0%1,698,654Added
Woodline Partners LP$20.6M2.8%1,582,291New
Citadel Advisors LLC$16.9M2.3%1,297,972Added
Redmile Group, LLC$16.0M2.2%1,226,330New
Great Point Partners LLC$13.0M1.8%1,000,000Trimmed
Affinity Asset Advisors, LLC$12.7M1.7%972,000Added
Millennium Management LLC$11.8M1.6%908,198Trimmed
ADAR1 Capital Management, LLC$10.7M1.5%822,649Added
Driehaus Capital Management LLC$10.3M1.4%790,000Added
Geode Capital Management, LLC$10.2M1.4%782,199Added
Stempoint Capital LP$9.7M1.3%742,745New
State Street Corp$9.0M1.2%686,772Added
Ameriprise Financial Inc$8.6M1.2%657,971New
Parkman Healthcare Partners LLC$7.3M1.0%563,484New
Superstring Capital Management LP$6.8M0.9%521,082Added
Sphera Funds Management LTD.$6.3M0.9%483,747Added

Share of 13F holdings is each fund's shares as a share of the 56,329,704 CLYM shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. FMR LLC Added+$88.5M
  2. UBS Group AG Added+$43.3M
  3. Adage Capital Partners GP, L.l.c. New+$32.7M
  4. Cormorant Asset Management, LP New+$27.5M
  5. BlackRock, Inc. Added+$25.5M
  6. Frontier Capital Management Co LLC New+$25.3M
  7. Woodline Partners LP New+$20.6M
  8. Braidwell LP Added+$16.5M
  9. Redmile Group, LLC New+$16.0M
  10. Citadel Advisors LLC Added+$12.4M

Biggest sellers in Q2 2026

  1. MPM Bioimpact LLC Sold out-$17.8M
  2. Kynam Capital Management, LP Sold out-$6.9M
  3. Marshall Wace, LLP Sold out-$5.3M
  4. Millennium Management LLC Trimmed-$4.8M
  5. Silverarc Capital Management, LLC Sold out-$4.7M
  6. Susquehanna International Group, LLP Trimmed-$4.7M
  7. Great Point Partners LLC Trimmed-$4.4M
  8. Two Sigma Investments, LP Trimmed-$2.1M
  9. Diadema Partners LP Sold out-$2.0M
  10. Longaeva Partners L.P. Sold out-$1.5M

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $416M and sold $64.1M; 32 added and 18 trimmed.

Schedule 13D and 13G filings on CLYM

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about CLYM ownership

Who owns CLYM stock?
109 institutional investment managers reported CLYM positions in their Form 13F filings for Q2 2026, holding 56,329,704 shares worth $734M in total. Ra Capital Management, L.p. reported the largest position.
Are funds buying or selling CLYM?
In Q2 2026, 52 managers opened new CLYM positions, 32 added, 18 trimmed and 22 sold out. Managers that filed in both quarters added a net 24,040,535 shares.
How current is this CLYM institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CLYM by CUSIP. Options are left out. CLYM news and filings · CLYM insider trades · Top funds